Yarrow Bioscience, Inc. (YARW)
40.26
+1.01
(+2.57%)
USD |
NASDAQ |
Aug 26, 09:45
Yarrow Bioscience 1 Year Total Returns (Daily) : 332.2% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 332.2% |
| August 24, 2026 | 323.5% |
| August 21, 2026 | 304.1% |
| August 20, 2026 | 318.2% |
| August 19, 2026 | 336.6% |
| August 18, 2026 | 332.2% |
| August 17, 2026 | 322.6% |
| August 14, 2026 | 334.9% |
| August 13, 2026 | 340.3% |
| August 12, 2026 | 340.8% |
| August 11, 2026 | 351.1% |
| August 10, 2026 | 321.1% |
| August 07, 2026 | 293.4% |
| August 06, 2026 | 308.5% |
| August 05, 2026 | 274.9% |
| August 04, 2026 | 272.2% |
| August 03, 2026 | 240.9% |
| July 31, 2026 | 243.0% |
| July 30, 2026 | 196.8% |
| July 29, 2026 | -24.27% |
| July 28, 2026 | -30.72% |
| July 27, 2026 | -29.95% |
| July 24, 2026 | -31.98% |
| July 23, 2026 | -36.32% |
| July 22, 2026 | -19.86% |
| Date | Value |
|---|---|
| July 21, 2026 | -26.22% |
| July 20, 2026 | -30.36% |
| July 17, 2026 | -36.58% |
| July 16, 2026 | -39.09% |
| July 15, 2026 | -41.30% |
| July 14, 2026 | -46.54% |
| July 13, 2026 | -53.67% |
| July 10, 2026 | -53.80% |
| July 09, 2026 | -53.33% |
| July 08, 2026 | -52.88% |
| July 07, 2026 | -48.08% |
| July 06, 2026 | -53.15% |
| July 02, 2026 | -54.97% |
| July 01, 2026 | -61.53% |
| June 30, 2026 | -60.56% |
| June 29, 2026 | -54.40% |
| June 26, 2026 | -59.98% |
| June 25, 2026 | -52.43% |
| June 24, 2026 | -38.62% |
| June 23, 2026 | -28.89% |
| June 22, 2026 | -26.97% |
| June 18, 2026 | -32.43% |
| June 17, 2026 | -31.30% |
| June 16, 2026 | -30.53% |
| June 15, 2026 | -30.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Oramed Pharmaceuticals, Inc. | 156.4% |
| NRX Pharmaceuticals, Inc. | 36.43% |
| ANI Pharmaceuticals, Inc. | -16.24% |
| Corcept Therapeutics, Inc. | 79.56% |
| Veru, Inc. | -22.35% |